Quality of Life Assessment in Patients With Epilepsy Using QOLIE-31
Assessment of Health-Related Quality of Life in Adults With Epilepsy Using the Quality of Life in Epilepsy Inventory (QOLIE-31): A Cross-Sectional Observational Study
1 other identifier
observational
90
1 country
1
Brief Summary
This observational study aims to assess quality of life in individuals with epilepsy using the Quality of Life in Epilepsy Inventory (QOLIE-31). A total of 90 adult patients with a clinical diagnosis of epilepsy will be evaluated through standardized questionnaires administered during routine clinical visits. The study seeks to characterize patient-reported quality of life across multiple domains and to provide insight into factors affecting daily functioning and well-being in people living with epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
February 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedFirst Posted
Study publicly available on registry
March 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedApril 30, 2026
February 1, 2026
28 days
February 26, 2026
April 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of life measured by QOLIE-31 total score
The Quality of Life in Epilepsy Inventory-31 is a validated epilepsy-specific quality of life scale consisting of 31 items. The total score ranges from 0 to 100. Higher scores indicate better health-related quality of life.
At study enrollment
Study Arms (1)
epilepsy
Eligibility Criteria
Adult patients with a confirmed diagnosis of epilepsy who are receiving routine care at a neurology clinic and are able to complete the QOLIE-31 questionnaire will be included. The population reflects individuals with varying clinical characteristics encountered in everyday epilepsy practice.
You may qualify if:
- Age ≥18 years
- Clinical diagnosis of epilepsy confirmed by a neurologist
- Ability to complete QOLIE-31 questionnaire
- Informed consent provided
You may not qualify if:
- Severe cognitive impairment
- Acute medical or psychiatric condition interfering with participation
- Inability to understand questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saglik Bilimleri University Izmir Faculty of Medicine Department of Neurology
Izmir, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2026
First Posted
March 4, 2026
Study Start
February 1, 2026
Primary Completion
March 1, 2026
Study Completion
April 1, 2026
Last Updated
April 30, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share